Marc Feldmann is Director of 180 Life Sciences Corp.. Currently has a direct ownership of 250,874 shares of ATNF, which is worth approximately $551,922. The most recent transaction as insider was on Dec 28, 2023, when has been sold 135,377 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 251K
0% 3M change
91.07% 12M change
Total Value Held $551,922

Marc Feldmann Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2023
BUY
Grant, award, or other acquisition
-
135,377 Added 35.05%
250,874 Common Stock
Dec 15 2023
SELL
Open market or private sale
$4,750 $0.19 p/Share
25,000 Reduced 17.79%
115,497 Common Stock
Dec 09 2021
BUY
Open market or private purchase
$203,500 $4.07 p/Share
50,000 Added 1.75%
2,809,930 Common Stock
Dec 08 2021
BUY
Grant, award, or other acquisition
$21,867 $3.95 p/Share
5,536 Added 0.2%
2,759,930 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
$819,816 $6.0 p/Share
136,636 Added 4.73%
2,754,394 Common Stock
Apr 07 2021
BUY
Grant, award, or other acquisition
$128,387 $6.14 p/Share
20,910 Added 0.79%
2,617,758 Common Stock
MF

Marc Feldmann

Director
Palo Alto, CA

Track Institutional and Insider Activities on ATNF

Follow 180 Life Sciences Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATNF shares.

Notify only if

Insider Trading

Get notified when an 180 Life Sciences Corp. insider buys or sells ATNF shares.

Notify only if

News

Receive news related to 180 Life Sciences Corp.

Track Activities on ATNF